Despite momentous breakthroughs in unraveling the pathophysiology of many chronic conditions and developing novel therapeutic agents, everyday clinical practice is still fraught with inadequate or inappropriate use of treatments with proven benefits. Aspirin is a paradigmatic example, as it is used for the primary and secondary prevention of cardiovascular disease and appears to have a beneficial impact on cancer risk. Yet, underuse, non-compliance or cessation of aspirin are not uncommon, may have an important clinical impact, and are not aggressively prevented or managed. Increasing the awareness of the extent and impact of aspirin underuse, non-compliance or cessation, and intensifying efforts at preventing them are worthy goals likely to yield significant benefits on cardiovascular morbidity and mortality worldwide, and possibly also on cancer outcomes.

Aspirin underuse, non-compliance or cessation. Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease / Biondi-Zoccai, G; Wu, Y; Jr, Serrano CV; Frati, G; Agostoni, P. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - ELETTRONICO. - 182:(2015), pp. 148-154. [10.1016/j.ijcard.2014.12.091]

Aspirin underuse, non-compliance or cessation. Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease

Biondi-Zoccai, G;Frati, G;
2015

Abstract

Despite momentous breakthroughs in unraveling the pathophysiology of many chronic conditions and developing novel therapeutic agents, everyday clinical practice is still fraught with inadequate or inappropriate use of treatments with proven benefits. Aspirin is a paradigmatic example, as it is used for the primary and secondary prevention of cardiovascular disease and appears to have a beneficial impact on cancer risk. Yet, underuse, non-compliance or cessation of aspirin are not uncommon, may have an important clinical impact, and are not aggressively prevented or managed. Increasing the awareness of the extent and impact of aspirin underuse, non-compliance or cessation, and intensifying efforts at preventing them are worthy goals likely to yield significant benefits on cardiovascular morbidity and mortality worldwide, and possibly also on cancer outcomes.
2015
aspirin; cardiovascular disease; cessation
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Aspirin underuse, non-compliance or cessation. Definition, extent, impact and potential solutions in the primary and secondary prevention of cardiovascular disease / Biondi-Zoccai, G; Wu, Y; Jr, Serrano CV; Frati, G; Agostoni, P. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - ELETTRONICO. - 182:(2015), pp. 148-154. [10.1016/j.ijcard.2014.12.091]
File allegati a questo prodotto
File Dimensione Formato  
Biondi-Zoccai_Aspirin-underuse_2015.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 379.62 kB
Formato Adobe PDF
379.62 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/780515
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 6
social impact